ESR1 and inflammatory breast carcinoma: In combination with our data, this suggests that IBC is generally characterised by overexpression of EGFR and/or ErbB2, leading to MAPK-induced activation of NF-κB, which then in turn results in RhoC overexpression and loss of ER expression.